SI1525188T1 - Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo - Google Patents

Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo

Info

Publication number
SI1525188T1
SI1525188T1 SI200331379T SI200331379T SI1525188T1 SI 1525188 T1 SI1525188 T1 SI 1525188T1 SI 200331379 T SI200331379 T SI 200331379T SI 200331379 T SI200331379 T SI 200331379T SI 1525188 T1 SI1525188 T1 SI 1525188T1
Authority
SI
Slovenia
Prior art keywords
aminobutane
dithiobis
sulphonates
compositions containing
containing same
Prior art date
Application number
SI200331379T
Other languages
English (en)
Inventor
Marie-Claude Fournie-Zaluski
Catherine Llorens-Cortes
Bernard P Roques
Pierre Corvol
Original Assignee
Edicale Inserm Inst Nat De La
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0208977A external-priority patent/FR2842522B1/fr
Priority claimed from FR0303425A external-priority patent/FR2852597A1/fr
Application filed by Edicale Inserm Inst Nat De La filed Critical Edicale Inserm Inst Nat De La
Publication of SI1525188T1 publication Critical patent/SI1525188T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200331379T 2002-07-16 2003-07-16 Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo SI1525188T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0208977A FR2842522B1 (fr) 2002-07-16 2002-07-16 Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositons les contenant
FR0303425A FR2852597A1 (fr) 2003-03-20 2003-03-20 Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
PCT/FR2003/002242 WO2004007441A2 (fr) 2002-07-16 2003-07-16 Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
EP03753648A EP1525188B1 (fr) 2002-07-16 2003-07-16 Derives de 4,4 -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant

Publications (1)

Publication Number Publication Date
SI1525188T1 true SI1525188T1 (sl) 2008-12-31

Family

ID=30117028

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331379T SI1525188T1 (sl) 2002-07-16 2003-07-16 Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo

Country Status (11)

Country Link
US (1) US7235687B2 (sl)
EP (1) EP1525188B1 (sl)
AT (1) ATE400552T1 (sl)
AU (1) AU2003271811A1 (sl)
CY (1) CY1109013T1 (sl)
DE (1) DE60322064D1 (sl)
DK (1) DK1525188T3 (sl)
ES (1) ES2309336T3 (sl)
PT (1) PT1525188E (sl)
SI (1) SI1525188T1 (sl)
WO (1) WO2004007441A2 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2533767T3 (es) 2005-04-15 2015-04-15 Epigenomics Ag Métodos para el análisis de trastornos proliferativos celulares
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
EP2322514A1 (en) * 2009-11-11 2011-05-18 Bayer Schering Pharma Aktiengesellschaft Homoglutamic acid and glutamic acid derivatives
EP2439192A1 (en) 2010-10-07 2012-04-11 Quantum Genomics Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)
SI2793878T1 (sl) 2011-12-21 2017-07-31 Quantum Genomics Tour Montparnasse Kombinacija (3s,3s')4,4'-disulfandiilbis (3-aminobutan 1-sulfonska kislina) in drugo antihipertenzivno sredstvo
EP2722327A1 (en) * 2012-10-22 2014-04-23 Quantum Genomics Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine
EP3207036A4 (en) * 2014-10-17 2018-08-15 University of Florida Research Foundation Novel small molecule anticancer agents
US10501426B1 (en) 2019-01-11 2019-12-10 King Saud University Synthesis of thiazole derivative as anticancer and anti-antibiotics resistant bacteria agent
CN110845347B (zh) * 2019-11-21 2021-10-15 利尔化学股份有限公司 一种氯代高丝氨酸烷基酯的制备方法
TW202207917A (zh) 2020-05-06 2022-03-01 法商量子基因科技有限公司 包含腦胺肽酶抑制劑、利尿劑及全身性腎素－血管收縮素系統阻斷劑之醫藥組合物
WO2022225712A1 (en) 2021-04-22 2022-10-27 Teva Pharmaceuticals International Gmbh Solid state forms of firibastat and processes for preparation thereof
CN115448833B (zh) * 2022-08-25 2024-07-05 湖北泰盛化工有限公司 一种多官能团脂肪族伯醇衍生物的羟基直接氯代方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773712B1 (fr) * 1998-01-16 2000-06-02 Inst Nat Sante Rech Med Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a

Also Published As

Publication number Publication date
US20060135602A1 (en) 2006-06-22
PT1525188E (pt) 2008-10-16
AU2003271811A8 (en) 2004-02-02
DE60322064D1 (de) 2008-08-21
ES2309336T3 (es) 2008-12-16
WO2004007441A3 (fr) 2004-04-08
ATE400552T1 (de) 2008-07-15
CY1109013T1 (el) 2014-07-02
US7235687B2 (en) 2007-06-26
AU2003271811A1 (en) 2004-02-02
DK1525188T3 (da) 2008-11-17
EP1525188B1 (fr) 2008-07-09
WO2004007441A2 (fr) 2004-01-22
EP1525188A2 (fr) 2005-04-27

Similar Documents

Publication Publication Date Title
MY127718A (en) Dolastatin 10 derivatives.
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
IL160028A0 (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them and their use in therapy
MX9706069A (es) Nuevos inhibidores de la trombina.
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0401538A3 (en) Novel derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and pharmaceutical compositions containing same
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
MX9706647A (es) Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina.
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
AU1185801A (en) Novel compounds
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
HK1055947A1 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-Ä1,2,4Ütriazol, methods for producing them and pharmaceutical compositions containing them
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
GEP20074100B (en) Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising the same
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
UA81664C2 (ru) Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
MY118101A (en) New 17-halogeno-19-nor-steroids, a process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions comprising them